← All Ionis Pharmaceuticals INC filings

Ionis Pharmaceuticals INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
IONS
Ionis Pharmaceuticals INC
DEF: Ionis Pharmaceuticals Sets 2026 Annual Meeting Date
Ionis Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 4, 2026, with key proposals including director elections and equity plan amendments.
NASDAQ
IONS
Ionis Pharmaceuticals INC
DEFA14A: Ionis Pharmaceuticals Files Definitive Proxy Statement
Ionis Pharmaceuticals has filed a definitive proxy statement related to its upcoming shareholder meeting.
NASDAQ
IONS
Ionis Pharmaceuticals INC
DEF: Ionis Pharmaceuticals Seeks Stockholder Approval for Equity Incentive Plan Amendment at 2025 Annual Meeting
Ionis Pharmaceuticals is asking stockholders to approve an amendment to its 2011 Equity Incentive Plan to increase the number of shares available for issuance by 4,000,000 at the 2025 annual meeting.
NASDAQ
IONS
Ionis Pharmaceuticals INC
DEFA14A: Ionis Pharmaceuticals Files Definitive Proxy Statement
Ionis Pharmaceuticals has filed a definitive proxy statement related to its upcoming shareholder meeting.
NASDAQ
IONS
Ionis Pharmaceuticals INC
DEF 14A: Ionis Pharmaceuticals Sets Agenda for 2024 Annual Stockholders Meeting
Ionis Pharmaceuticals invites stockholders to its virtual 2024 Annual Meeting on June 6, 2024, featuring director elections, executive compensation advisory vote, and equity incentive plan amendment approval.